中文别名:
甲基甲唑啉杂质;赛洛唑啉;2-(4-叔丁基-2,6-二甲基苄基)-4,5-二氢-1H-咪唑;羟甲唑啉EP杂质B;盐酸羟甲唑啉杂质B;盐酸羟甲唑啉EP杂质B;盐酸羟甲唑啉B;羟甲唑啉杂质2(羟甲唑啉EP杂质B)
英文别名:
XYLOMETAZOLINE;2-(4-TERT-BUTYL-2,6-DIMETHYL-BENZYL)-4,5-DIHYDRO-1H-IMIDAZOLE;AKOS BBS-00000259;XYLOMETAZOLINEANDITSHYDROCHLORIDE;Xylometazoline (base and/or unspecified salts);1h-imidazole,2-((4-(1,1-dimethylethyl)-2,6-dimethylphenyl)methyl)-4,5-dihydr;2-(4-tert-butyl-2,6-dimethylbenzyl)-2-imidazolin;2-(4-tert-Butyl-2,6-dimethylbenzyl)-2-imidazoline
InChI:
InChI=1/C16H24N2/c1-11-8-13(16(3,4)5)9-12(2)14(11)10-15-17-6-7-18-15/h8-9H,6-7,10H2,1-5H3,(H,17,18)/p+1
密度:
1.00±0.1 g/cm3(Predicted)
沸点:
394.2±21.0 °C(Predicted)
产品用途:
赛洛唑啉具有直接激动α1受体而引起血管收缩的作用,从而减轻炎症所致的充血和水肿,临床上用以减轻急慢性鼻炎、鼻窦炎、过敏性鼻炎、肥厚性鼻炎等疾病引起的鼻塞症状。